Suggestions
Blake Jensen
Quality and Compliance Executive
Professional Background
Blake Jensen is a well-respected professional in the field of clinical development quality assurance and compliance, with extensive experience that spans various prestigious organizations in the biotechnology and pharmaceutical sectors. Currently serving as the Vice President of Clinical Development Quality Assurance and Compliance at Adagio Therapeutics, Blake brings an in-depth understanding of quality systems and regulatory compliance to his role. His career has been characterized by a commitment to preserving the integrity of clinical research and ensuring adherence to stringent quality standards, which is essential in today’s highly regulated environment.
Before joining Adagio Therapeutics, Blake held multiple key positions that have significantly shaped his expertise in quality assurance. He was formerly the Vice President of Quality and Compliance at G1 Therapeutics, Inc., where he honed his skills in navigating complex regulatory landscapes and ensuring product quality throughout the clinical development process. His prior experience also includes roles such as Director of Quality and Compliance at Precision BioSciences, Inc., and Senior Director of Quality Systems and Compliance at Heat Biologics. Each position has afforded him unique insights into the nuances of compliance and risk management, further enhancing his capabilities as a leader in the industry.
Blake’s career in quality assurance began at PPD as the Executive Director of Quality Risk Management, where he played a pivotal role in establishing a comprehensive risk management framework. He has also served as the Senior Director of Quality Assurance at INC Research, allowing him to refine his approach to clinical trial management and compliance strategies. Additionally, his distinguished early career as an Investigator at the Food and Drug Administration (FDA) equipped him with invaluable regulatory insight and a deep understanding of the expectations placed on clinical developers by government agencies.
Education and Achievements
Blake Jensen’s robust educational background sets the foundation for his successful career in quality assurance and compliance. He earned his Master of Business Administration (M.B.A.) from the University of North Carolina at Wilmington, an institution known for its focus on developing the next generation of business leaders. This advanced degree has provided Blake with essential skills in management, strategic leadership, and operational excellence, enabling him to effectively guide teams within the typically fast-paced and high-stakes environments of biotechnology and pharmaceuticals.
Prior to achieving his M.B.A., Blake completed a Bachelor of Science degree in Biology and Chemistry at the University of Utah. His dual focus in these scientific disciplines has equipped him with a robust understanding of the scientific principles that underpin drug development and clinical research, further informing his work in compliance and quality assurance. His educational journey reflects his commitment to blending scientific expertise with business acumen, fostering a holistic perspective crucial for success in his field.
Achievements
Throughout his impressive career, Blake has achieved noteworthy milestones that exemplify his dedication to quality and compliance in clinical development. As a leader, he has been instrumental in developing and implementing quality management systems that have not only met regulatory requirements but have also driven operational efficiencies across organizations.
In addition to his corporate responsibilities, Blake’s entrepreneurial spirit was showcased during his time as a co-owner of I Love Juice Bar, LLC. This venture allowed him to apply his business insights and operational expertise in a different context, further enriching his professional repertoire.
Blake's comprehensive understanding of compliance was further strengthened owing to his practical experiences at the FDA, which has provided him with a unique perspective on regulatory expectations and industry best practices. His focused approach to quality assurance has helped organizations navigate complex regulatory hurdles, bolster product development initiatives, and ultimately drive successful outcomes in clinical trials.
Furthermore, his contributions to the field extend beyond his day-to-day roles; Blake is an advocate for promoting quality assurance practices and sharing knowledge across the industry. His engagements in various professional circles and forums continue to enhance his reputation as an industry thought leader, dedicated not only to the advancement of his organization but to the biotechnology and pharmaceutical industries as a whole.
